| Type | Title | Date Released | |
|---|---|---|---|
S-3 | November 2026 SHELF + ATM New | ||
S-3 | SHARE RESALE REGISTRATION + SPA New | ||
10-Q | Form 10-Q New | ||
8-K | Turn Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Updates New | ||
ARS | Form ARS | ||
DEF 14A | Form DEF 14A | ||
8-K | Turn Therapeutics Corporate Presentation Outlines Pipeline and GX-03 Phase 2 Milestones | ||
8-K | Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum | ||
8-K | Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer | ||
D | Form D | ||
8-K | Turn Therapeutics Inc. Announces Full Cashless Exercise of Warrant by GEM Yield Bahamas Limited | ||
8-K | Turn Therapeutics Inc. Announces $1.35 Million Private Placement |